A high calcium intake, from diet or the combination of diet and supplements may raise the rate of mortality, especially cardiovascular (CV) mortality.
A high calcium intake, from diet or the combination of diet and supplements may raise the rate of mortality, especially cardiovascular (CV) mortality, said a study in the British Medical Journal (BMJ).
In an observational cohort study, Swedish researchers followed approximately 61,000 women, aged, on average, 53 years at baseline. Information about dietary and lifestyle habits were assessed by questionnaires. Based on the questionnaire information, calcium intake from diet and supplements was estimated. During follow-up (at about 20 years), 12,000 of the women died. Death rates by calcium intake levels were assessed.
“We found a higher risk of mortality, especially CV mortality with a high calcium intake,” Karl Michaëlsson, clinical professor, Department of Surgical Sciences and Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden, told Formulary.
“On the other hand, we also found a higher risk of mortality associated with a low calcium intake but this latter finding was not confirmed by us in our sensitivity analysis,” he said. “The higher risk of death was seen with a higher dietary calcium intake. This risk increase was modest. If we did not consider the dietary component of calcium intake, we found on average no association with calcium supplement use and mortality.”
However, women who consumed a high dietary calcium intake together with calcium supplements had a higher mortality rate, even though few had this combination in the cohort.
A research group from Auckland, New Zealand, previously published 3 re-analyses of randomized studies in BMJ. “They have shown a moderate higher risk of CV disease with calcium supplement use,” Michaëlsson said. “In one of their analysis they also considered dietary calcium intake in addition to the calcium supplement.”
They found that the higher risk of CV disease with calcium supplement use was only predominant in combination with a high dietary calcium intake. “However, other researchers have also re-examined their randomized trials and have not found a higher risk of CV disease,” he said. “A complicating fact is that the methodologies of the re-examinations have differed. Cautious interpretation of all observational study results is always needed but our findings fit those from the New Zealand research group.” â
Coalition promotes important acetaminophen dosing reminders
November 18th 2014It may come as a surprise that each year Americans catch approximately 1 billion colds, and the Centers for Disease Control and Prevention estimates that as many as 20% get the flu. This cold and flu season, 7 in 10 patients will reach for an over-the-counter (OTC) medicine to treat their coughs, stuffy noses, and sniffles. It’s an important time of the year to remind patients to double check their medicine labels so they don’t double up on medicines containing acetaminophen.
Support consumer access to specialty medications through value-based insurance design
June 30th 2014The driving force behind consumer cost-sharing provisions for specialty medications is the acquisition cost and not clinical value. This appears to be true for almost all public and private health plans, says a new report from researchers at the University of Michigan Center for Value-Based Insurance Design (V-BID Center) and the National Pharmaceutical Council (NPC).
Management of antipsychotic medication polypharmacy
June 13th 2013Within our healthcare-driven society, the increase in the identification and diagnosis of mental illnesses has led to a proportional increase in the prescribing of psychotropic medications. The prevalence of mental illnesses and subsequent treatment approaches may employ monotherapy as first-line treatment, but in many cases the use of combination of therapy can occur, leading to polypharmacy.1 Polypharmacy can be defined in several ways but it generally recognized as the use of multiple medications by one patient and the most common definition is the concurrent use of five more medications. The presence of polyharmacy has the potential to contribute to non-compliance, drug-drug interactions, medication errors, adverse events, or poor quality of life.
Medical innovation improves outcomes
June 12th 2013I have been diagnosed with stage 4 cancer of the pancreas, a disease that’s long been considered not just incurable, but almost impossible to treat-a recalcitrant disease that some practitioners feel has given oncology a bad name. I was told my life would be measured in weeks.